Fluorouracil Injection, Solution
Product Images NDC 16729-276

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fluorouracil (NDC 16729-276). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (500 mg/10 mL Vial-Carton)

Description: Fluorouracil Injection, USP is a sterile, nonpyrogenic, cytotoxic agent used for intravenous use only. The package contains 10 x 10 mL single-dose vials for usual dosage, see accompanying prescribing information. The vial consists of 500 mg Fluorouracil USP, water for injection, adjusted pH, and sodium hydroxide. Storage recommended at 20°C to 25°C (68" to 77°F), protect from light, and do not freeze. Precipitation can occur on exposure to low temperatures, which can be resolved by heating it to 60°C, with vigorous shaking. It is manufactured by Intas Pharmaceuticals in Ahmedabag, India.*

FDA Label Image

Principal Display Panel (500 mg/10 mL Vial-Label)

This is a description of Fluorouracil Injection USP, a cytotoxic agent used intravenously. The drug is sterile, non-pyrogenic and comes in a single-use vial containing 500mg of Fluorouracil with instructions for dosing usage provided in the package insert. The pH is adjusted to 9.2 using sodium hydroxide and the drug must be stored at a temperature range between 20-25°C, protected from light, and discarded after use. If a precipitate forms, it can be resolubilized by heating to 60°C and shaking vigorously. The product is manufactured by Intas Pharmaceuticals Limited, India and is sold by Accord Healthcare Inc., NC, USA.*

FDA Label Image

Principal Display Panel -1 G/20 mL Vial Carton (Fluorouracil Inj 20ml Carton)

Fluorouracil Injection is designated as a cytotoxic drug. It is indicated in the treatment of cancer, including breast, colorectal, gastrointestinal, and other cancers. Each vial of Fluorouracil, USP 1g contains Fluorouracil injection, USP mimeciast. The injection is for intravenous use only and should be stored at 20°C to 25°C. It comes in 10 x 20 mL single-dose vials and should be discarded after use. Precipitated forms can be resolved by heating to 60°C. Fluorouracil Injection is manufactured by Intas Pharmaceuticals Limited in Ahmedabad, India. Mfg. Lic. No.: 6/28/1336.*

FDA Label Image

Principal Display Panel -1 G/20 mL Vial Label (Fluorouracil Inj 20ml Label)

This is a description of a medication called Fluorouracil Injection USP, presented in a single-dose vial containing 1g/20mL of the drug. The drug should be used only after a doctor's prescription and is for intravenous use only. It should be stored at 20° to 25°C and protected from light. If a precipitate forms due to exposure to low temperatures, it can be resolubilized by heating to 10 to 60°C with vigorous shaking. It has cytotoxic properties and requires caution when in use. The rest of the included text seems to be unreadable characters due to the process.*

FDA Label Image

Fluorouracil Structure (Fluorouracil Inj Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.